Back | Next |
home / stock / xbit / xbit message board
Subject | By | Source | When |
---|---|---|---|
Lets get to 30! | amarinbullfromchicago | investorshub | 04/29/2020 9:53:14 PM |
Broke resistance now lets close hard then its | starkd748 | investorshub | 04/29/2020 6:28:58 PM |
Volume and power | starkd748 | investorshub | 04/29/2020 3:42:38 PM |
Close no cigar lol | starkd748 | investorshub | 04/27/2020 8:34:22 PM |
Broken see hoow she closes | starkd748 | investorshub | 04/27/2020 6:57:38 PM |
Lets see if we break resistance | starkd748 | investorshub | 04/27/2020 3:58:30 PM |
Weeeeeee super green | starkd748 | investorshub | 04/27/2020 3:54:30 PM |
https://youtu.be/-KfN4R8mqqg Trump agrees to funding fir more testing | starkd748 | investorshub | 04/22/2020 9:57:23 AM |
https://www.cnbc.com/2020/04/19/trump-to-use-defense-production-act-to-increase- | starkd748 | investorshub | 04/20/2020 2:36:46 AM |
Yea looking a lot better | starkd748 | investorshub | 04/19/2020 11:01:47 PM |
I think we see 20 easily soon. And | amarinbullfromchicago | investorshub | 04/19/2020 11:01:13 PM |
Thats gold need a pr about then 20s | starkd748 | investorshub | 04/19/2020 5:34:11 PM |
Yea | starkd748 | investorshub | 04/19/2020 5:05:42 PM |
I guess their a private company. | tomj1 | investorshub | 04/19/2020 3:48:40 PM |
SORRY HERE IS THE LINK ITS ACCUBIOTECH | tomj1 | investorshub | 04/19/2020 3:40:06 PM |
HERE IS THE LINK $SEE SLIDE 25 | tomj1 | investorshub | 04/19/2020 3:21:22 PM |
When did the test kit come out...Link... | starkd748 | investorshub | 04/19/2020 2:48:55 PM |
STARK LOOKS LIKE$ XBIT COVID-19 TEST KIT ON | tomj1 | investorshub | 04/19/2020 2:44:45 PM |
https://time.com/5819068/fauci-coronavirus-antibody-test-us/ Antibody tests ra | starkd748 | investorshub | 04/10/2020 11:36:21 PM |
Antibody tests are ramping up | starkd748 | investorshub | 04/10/2020 11:06:55 PM |
News, Short Squeeze, Breakout and More Instantly...
AUSTIN, Texas, June 18, 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today data from its Phase 1/Phase 2 randomized, double-blind, placebo-controlled multi-center study for advanced pancreatic cancer. Known as 1-BETTER, the study examined Natrunix (anti-interleukin-1alpha) anti...
2024-06-06 21:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-16 07:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...